Webinar

March 12 – March 12, 2025

Magnetic Peripheral Nerve Stimulation. A Drug-Free Alternative for Chronic Pain.

Magnetic Peripheral Nerve Stimulation. A Drug-Free Alternative for Chronic Pain.

Chronic pain affects millions worldwide, yet many treatments rely on medication or invasive procedures. Magnetic Peripheral Nerve Stimulation (mPNS) provides a non-invasive alternative.

Join our webinar to hear Prof. Daniel Ciampi de Andrade, a leading expert in neurology, as he explores the science behind Pain Therapy and how it is changing how we view pain management.

Key Outcomes  

  • Understanding what pain is
  • When pain becomes chronic
  • Pain and depression
  • Neuromodulation in pain management
  • The logic of peripheral stimulation to treat pain

Designed for doctors interested in the treatment of chronic pain, the session will be hosted by Kerry Rome, Senior Vice President, Sales and Marketing, MagVenture, who will conclude the webinar with an interactive Q&A with participants.

Date and Time  

  • 8:00am Wednesday 12 March 2025 (Pacific Time)
  • 11:00am Wednesday 12 March 2025 (Eastern Time)

Can’t attend? Register to receive the recording after the session.

Speaker Profile 
Daniel Ciampi de Andrade, Clinical Neurologist and Associate Professor, MD., PhD Aalborg University

Assoc. Prof. Daniel Ciampi de Andrade is an Associate Professor, Doctor, PhD, Neurologist and Lecturer currently located at the Aalborg University in Denmark, known for its high-quality research. His interests are in the assessment, diagnosis and management of chronic pain, with a focus on different neuromodulation approaches.   

Before relocating to Denmark, he was Head of the Pain Center, University of Sao Paulo, Head of the Pain research group (Pain Center, University of Sao Paulo) and coordinated of the lab Interventional Neuroscience, discipline of neurosurgery, University of Sao Paulo. 

The views and opinions expressed in this webinar do not necessarily reflect the official policy or position of MagVenture or any of its affiliates. The usage of mPNS for any other purpose than the cleared indication, in the country in which the product is intended to be used, is considered investigational.

Share article

Stay updated

Explore our instagram

Devsite – for testing purposes only!
Skip to content